A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic

- Lal, Anoushka P., Foong, Yi Chao, Roos, Izanne, Lechner-Scott, Jeannette, John, Nevin, Soysal, Aysun, D’Amico, Emanuele, Gouider, Riadh, Mrabet, Saloua, Gross-Paju, Katrin, Cárdenas‑Robledo, Simón, Moghadasi, Abdorreza Naser, Sanfilippo, Paul G., Sa, Maria Jose, Gray, Orla, Oh, Jiwon, Reddel, Stephen, Ramanathan, Sudarshini, Al-Harbi, Talal, Altintas, Ayse, Hardy, Todd A., Ozakbas, Serkan, Alroughani, Raed, Spelman, Tim, Kermode, Allan G., Surcinelli, Andrea, Laureys, Guy, Eichau, Sara, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Hodgkinson, Suzanne, Ramo-Tello, Cristina, Maimone, Davide, Rath, Louise, McCombe, Pamela, Spitaleri, Daniele, Sanchez-Menoyo, Jose Luis, Yetkin, Mehmet Fatih, Baghbanian, Seyed Mohammad, Karabudak, Rana, Al-Asmi, Abdullah, Jakob, Gregor Brecl, Khoury, Samia J., Etemadifar, Masoud, Levitz, David, van Pesch, Vincent, Buzzard, Katherine, Taylor, Bruce, Butzkueven, Helmut, Van der Walt, Anneke, Fabis-Pedrini, Marzena, Foschi, Matteo, Habek, Mario, Kalincik, Tomas

A new era in the treatment of multiple sclerosis

- Broadley, Simon A., Barnett, Michael H., Marriott, Mark, Mason, Deborah F., Parratt, John, Reddel, Stephen W., Shaw, Cameron P., Slee, Mark, Spies, Judith M., Taylor, Bruce V., Carroll, William M., Kilpatrick, Trevor J., Boggild, Mike, King, John, McCombe, Pamela A., Pollard, John D., Willoughby, Ernest, Brew, Bruce J., Butzkueven, Helmut, Heard, Robert, Hodgkinson, Suzanne, Kermode, Allan G., Lechner-Scott, Jeannette, Macdonell, Richard A. L.

Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects

- Lill, Christina M., Liu, Tian, Blaschke, Paul, Winkelmann, Alexander, Gerdes, Lisa-Ann, Luessi, Felix, Fernadez, Oscar, Izquierdo, Guillermo, Antiguedad, Alfredo, Hoffjan, Sabine, Cournu-Rebeix, Isabelle, Gromoller, Silvana, Schjeide, Brit-Maren M., Faber, Hans, Liebsch, Maria, Meissner, Esther, Chanvillard, Coralie, Touze, Emmauel, Pico, Fernando, Corcia, Philippe, Bahlo, Melanie, Booth, David R., Broadley, Simon, Roehr, Johannes T., Brown, Matthew A., Browning, Brian L., Browning, Sharon R., Butzkueven, Helmut, Carroll, William M., Cox, Mathew B., Chapman, Caron, Clarke, Glynnis, Danoy, Patrick, Drysdale, Karen, Akkad, Denis A., Field, Judith, Foote, Simon J., Greer, Judith M., Griffiths, Lyn R., Hadler, Johanna, Jensen, Cathy J., Johnson, Laura J., Kermode, Allan G., Heard, Robert N., Kilpatrick, Trevor J., Damotte, Vincent, Lechner-Scott, Jeanette, Marriott, Mark, Mason, Deborah, Moscato, Pablo, Pender, Michael P., Perreau, Victoria M., Rubio, Justin P., Scott, Rodney J., Slee, Mark, Stankovich, Jim, Alcina, Antonio, Stewart, Graeme J., Tajouri, Lofti, Taylor, Bruce V., Wiley, James, Wilkins, Ella J., Dörner, Thomas, Steinhagen-Thiessen, Elisabeth, Baeckman, Lars, Heekeren, Hauke R., Li, Shu-Chen, Ortiz, Miguel A., Lindenberger, Ulman, Chan, Andrew, Hartung, Hans-Peter, Aktas, Orhan, Lohse, Peter, Kümpfel, Tania, Kubisch, Christian, Epplen, Joerg T., Zettl, Uwe K., Fontaine, Bertrand, Arroyo, Rafa, Vandenbroeck, Koen, Matesanz, Fuencisla, Urcelay, Elena, Bertram, Lars, Zipp, Frauke, Lopez de Lapuente, Aitzkoa

Comparing genotyping algorithms for Illumina's Infinium whole-genome SNP BeadChips

- Ritchie, Matthew E., Ruijie, Liu, Kilpatrick, Trevor J., Lechner-Scott, Jeannette, Moscato, Pablo, Perreau, Victoria M., Rubio, Justin P., Scott, Rodney J., Stankovich, Jim, Stewart, Graeme J., Taylor, Bruce V., Wiley, James, Carvalho, Benilton S., Booth, David R., Clarke, Glynnis, Cox, Mathew B., Csurhes, Peter A., Danoy, Patrick, Dickinson, Joanne L., Drysdale, Karen, Field, Judith, Greer, Judith M., Griffiths, Lyn R., Irizarry, Rafael A., Guru, Preethi, Hadler, Johanna, Hoban, Ella, McMorran, Brendan J., Jensen, Cathy J., Johnson, Laura J., McCallum, Ruth, Merriman, Marilyn, Merriman, Tony, Polanowski, Andrea, Bahlo, Melanie, Pryce, Karena, Tajouri, Lotfi, Whittock, Lucy, Wilkins, Ella J., Browning, Brian L., Browning, Sharon R., Perera, Devindri, Butzkueven, Helmut, Carroll, William M., Chapman, Caron, Kermode, Allan G., Marriott, Mark, Mason, Deborah, Heard, Robert N., Pender, Michael P., Slee, Mark, Tubridy, Niall, Willoughby, Ernest, Broadley, Simon A., Brown, Matthew A., Foote, Simon J.

Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci

- Patsopoulos, Nikolaos A., de Bakker, Paul I. W., Kappos, Ludwig, Miller, David, Montalbán, Javier, Polman, Chris H., Freedman, Mark S., Hartung, Hans-Peter, Arnason, Barry G. W., Comi, Giancarlo, Cook, Stuart, Filippi, Massimo, Esposito, Federica, Goodin, Douglas S., Jeffery, Douglas, O'Connor, Paul, Ebers, George C., Langdon, Dawn, Reder, Anthony T., Traboulsee, Anthony, Zipp, Frauke, Schimrigk, Sebastian, Hillert, Jan, Reischl, Joachim, Bahlo, Melanie, Booth, David R., Broadley, Simon, Brown, Matthew A., Browning, Brian L., Browning, Sharon R., Butzkueven, Helmut, Carroll, William M., Chapman, Caron, Foote, Simon J., Lehr, Stephan, Griffiths, Lyn, Kermode, Allan G., Kilpatrick, Trevor J., Lechner-Scott, Jeannette, Marriott, Mark, Mason, Deborah, Moscato, Pablo, Heard, Robert N., Pender, Michael P., Perreau, Victoria M., Bauer, David, Perera, Devindri, Rubio, Justin P., Scott, Rodney J., Slee, Mark, Stankovich, Jim, Stewart, Graeme J., Taylor, Bruce V., Tubridy, Niall, Willoughby, Ernest, Wiley, James, Heubach, Jürgen, Matthews, Paul, Boneschi, Filippo M., Compston, Alastair, Haines, Jonathan, Hauser, Stephen L., McCauley, Jacob, Ivinson, Adrian, Oksenberg, Jorge R., Pericak-Vance, Margaret, Sawcer, Stephen J., Sandbrink, Rupert, De Jager, Philip L., Hafler, David A., Pohl, Christoph, Edan, Gilles

Polymorphisms in the receptor tyrosine kinase MERTK gene are associated with multiple sclerosis susceptibility

- Ma, Gerry Z. M., Stankovich, Jim, Browning, Sharon R., Butzkueven, Helmut, Carroll, William M., Danoy, Patrick, Foote, Simon J., Griffiths, Lyn, Heard, Robert N., Kermode, Allan G., Lechner-Scott, Jeannette, Moscato, Pablo, Kilpatrick, Trevor J., Perreau, Victoria M., Scott, Rodney J., Slee, Mark, Stewart, Graeme J., Taylor, Bruce V., Wiley, James, Binder, Michele D., Field, Judith, Bahlo, Melanie, Booth, David R., Broadley, Simon, Brown, Matthew A., Browning, Brian L.

Prediction of multiple sclerosis outcomes when switching to ocrelizumab

- Zhong, Michael, van der Walt, Anneke, Macdonell, Richard, Prevost, Julie, Kuhle, Jens, Laureys, Guy, Van Hijfte, Liesbeth, Alroughani, Raed, Kermode, Allan G., Butler, Ernest, Barnett, Michael, Eichau, Sara, Stankovich, Jim, van Pesch, V, Grammond, P, McCombe, P, Karabudak, R, Duquette, P, Girard, M, Taylor, B, Yeh, W, Monif, M, Gresle, M, Kalincik, Tomas, Butzkueven, H, Jokubaitis, VG, Buzzard, Katherine, Skibina, Olga, Boz, Cavit, Hodgkinson, Suzanne, Slee, Mark, Lechner-Scott, Jeanette

The MOG antibody non-P42 epitope is predictive of a relapsing course in MOG antibody-Associated disease

- Liyanage, Ganesha, Trewin, Benjamin P., Buckland, Ali, Fok, Anthony, Barnett, Michael H., Reddel, Stephen W., Marignier, Romain, El Hajj, Aseel, Monif, Mastura, van der Walt, Anneke, Lechner-Scott, Jeannette, Kermode, Allan G., Lopez, Joseph A., Kalincik, T, Broadley, SA, Dale, RC, Ramanathan, S, Brilot, F, Andersen, Jane, Tea, Fiona, Merheb, Vera, Nguyen, Kristy, Lee, Fiona X. Z., Fabis-Pedrini, Marzena J., Zou, Alicia

The MS risk allele of CD40 is associated with reduced cell-membrane bound expression in antigen presenting cells: implications for gene function

- Field, Judith, Shahijanian, Fernando, Butzkueven, Helmut, Booth, David, Baxter, Alan, Kermode, Allan G., Taylor, Bruce, Booth, David R., Mason, Deborah, Stewart, Graeme J., Charlesworth, Jac, Schibeci, Stephen, Wiley, James, Lechner-Scott, Jeannette, Tajouri, Lotti, Griffiths, Lyn, Slee, Mark, Brown, Matthew A., Moscato, Pablo, Scott, Rodney J., Broadley, Simon, Johnson, Laura, Vucic, Steve, Kilpatrick, Trevor, Carroll, William M., Gresle, Melissa, Laverick, Louise, Parnell, Grant, Stewart, Graeme, McKay, Fiona

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 1 Historical and established therapies

- Broadley, Simon A., Barnett, Michael H., Marriott, Mark, Mason, Deborah F., Parratt, John, Reddel, Stephen W., Shaw, Cameron P., Slee, Mark, Spies, Judith, Taylor, Bruce V., Carroll, William M., Kilpatrick, Trevor J., Boggild, Mike, King, John, McCombe, Pamela A., Pollard, John D., Willoughby, Ernest, Brew, Bruce J., Butzkueven, Helmut, Heard, Robert, Hodgkinson, Suzanne, Kermode, Allan G., Lechner-Scott, Jeannette, Macdonell, Richard A. L.

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 2 New and emerging therapies and their efficacy

- Broadley, Simon A., Barnett, Michael H., Marriott, Mark, Mason, Deborah F., Parratt, John, Reddel, Stephen W., Shaw, Cameron P., Slee, Mark, Spies, Judith, Taylor, Bruce V., Carroll, William M., Kilpatrick, Trevor J., Boggild, Mike, King, John, McCombe, Pamela A., Pollard, John D., Willoughby, Ernest, Brew, Bruce J., Butzkueven, Helmut, Heard, Robert, Hodgkinson, Suzanne, Kermode, Allan G., Lechner-Scott, Jeannette, Macdonell, Richard A. L.

Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 3 Treatment practicalities and recommendations

- Broadley, Simon A., Barnett, Michael H., Marriott, Mark, Mason, Deborah F., Parratt, John, Reddel, Stephen W., Shaw, Cameron P., Slee, Mark, Spies, Judith, Taylor, Bruce V., Carroll, William M., Kilpatrick, Trevor J., Boggild, Mike, King, John, McCombe, Pamela A., Pollard, John D., Willoughby, Ernest, Brew, Bruce J., Butzkueven, Helmut, Heard, Robert, Hodgkinson, Suzanne, Kermode, Allan G., Lechner-Scott, Jeannette, Macdonell, Richard A. L.